These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 18025996

  • 1. No increase in cervicovaginal proinflammatory cytokines after Carraguard use in a placebo-controlled randomized clinical trial.
    Bollen LJ, Blanchard K, Kilmarx PH, Chaikummao S, Connolly C, Wasinrapee P, Srivirojana N, Achalapong J, Tappero JW, McNicholl JM.
    J Acquir Immune Defic Syndr; 2008 Feb 01; 47(2):253-7. PubMed ID: 18025996
    [Abstract] [Full Text] [Related]

  • 2. Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa.
    van de Wijgert JH, Braunstein SL, Morar NS, Jones HE, Madurai L, Strickfaden TT, Moodley M, Aboobaker J, Ndlovu G, Ferguson TM, Friedland BA, Hart CE, Ramjee G.
    J Acquir Immune Defic Syndr; 2007 Dec 15; 46(5):538-46. PubMed ID: 18193495
    [Abstract] [Full Text] [Related]

  • 3. A randomized, placebo-controlled trial to assess the safety and acceptability of use of carraguard vaginal gel by heterosexual couples in Thailand.
    Kilmarx PH, Blanchard K, Chaikummao S, Friedland BA, Srivirojana N, Connolly C, Witwatwongwana P, Supawitkul S, Mock PA, Chaowanachan T, Tappero J.
    Sex Transm Dis; 2008 Mar 15; 35(3):226-32. PubMed ID: 18490865
    [Abstract] [Full Text] [Related]

  • 4. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.
    Yang J, Li L, Jin H, Tan S, Qiu J, Yang L, Ding Y, Jiang ZH, Jiang S, Liu S.
    AIDS Res Hum Retroviruses; 2012 Nov 15; 28(11):1498-508. PubMed ID: 22867271
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Safety and acceptability of the candidate microbicide Carraguard in Thai Women: findings from a Phase II Clinical Trial.
    Kilmarx PH, van de Wijgert JH, Chaikummao S, Jones HE, Limpakarnjanarat K, Friedland BA, Karon JM, Manopaiboon C, Srivirojana N, Yanpaisarn S, Supawitkul S, Young NL, Mock PA, Blanchard K, Mastro TD.
    J Acquir Immune Defic Syndr; 2006 Nov 01; 43(3):327-34. PubMed ID: 16980907
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial.
    Skoler-Karpoff S, Ramjee G, Ahmed K, Altini L, Plagianos MG, Friedland B, Govender S, De Kock A, Cassim N, Palanee T, Dozier G, Maguire R, Lahteenmaki P.
    Lancet; 2008 Dec 06; 372(9654):1977-87. PubMed ID: 19059048
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mucosal integrity and inflammatory markers in the female lower genital tract as potential screening tools for vaginal microbicides.
    Su HI, Schreiber CA, Fay C, Parry S, Elovitz MA, Zhang J, Shaunik A, Barnhart K.
    Contraception; 2011 Nov 06; 84(5):525-32. PubMed ID: 22018129
    [Abstract] [Full Text] [Related]

  • 16. Acceptability of Carraguard vaginal gel use among Thai couples.
    Whitehead SJ, Kilmarx PH, Blanchard K, Manopaiboon C, Chaikummao S, Friedland B, Achalapong J, Wankrairoj M, Mock P, Thanprasertsuk S, Tappero JW.
    AIDS; 2006 Nov 14; 20(17):2141-8. PubMed ID: 17086053
    [Abstract] [Full Text] [Related]

  • 17. Acceptability of a carrageenan-based candidate vaginal microbicide and matching placebo: findings from a phase II safety trial among women in Chiang Rai, Thailand.
    Jones HE, Chaikummao S, van de Wijgert JH, Friedland BA, Manopaiboon C, Witwatwongwana P, Wankrairot M, Chantharojwong N, Kilmarx PH.
    J Womens Health (Larchmt); 2009 Jul 14; 18(7):1003-10. PubMed ID: 19575689
    [Abstract] [Full Text] [Related]

  • 18. High Levels of Inflammatory Cytokines in the Reproductive Tract of Women with BV and Engaging in Intravaginal Douching: A Cross-Sectional Study of Participants in the Women Interagency HIV Study.
    Alcaide ML, Rodriguez VJ, Brown MR, Pallikkuth S, Arheart K, Martinez O, Roach M, Fichorova RN, Jones DL, Pahwa S, Fischl MA.
    AIDS Res Hum Retroviruses; 2017 Apr 14; 33(4):309-317. PubMed ID: 27897054
    [Abstract] [Full Text] [Related]

  • 19. Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.
    Keller MJ, Carpenter CA, Lo Y, Einstein MH, Liu C, Fredricks DN, Herold BC.
    PLoS One; 2012 Apr 14; 7(10):e46901. PubMed ID: 23056520
    [Abstract] [Full Text] [Related]

  • 20. Biocompatibility of solid-dosage forms of anti-human immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo.
    Trifonova RT, Pasicznyk JM, Fichorova RN.
    Antimicrob Agents Chemother; 2006 Dec 14; 50(12):4005-10. PubMed ID: 17030562
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.